Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia

Int J Lab Hematol. 2007 Dec;29(6):482-3. doi: 10.1111/j.1365-2257.2006.00887.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects*
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / adverse effects
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnostic imaging
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Pulmonary Edema / chemically induced*
  • Pulmonary Edema / diagnostic imaging
  • Radiography
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Antimetabolites, Antineoplastic
  • Glucocorticoids
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Methylprednisolone
  • Methotrexate

Supplementary concepts

  • CVAD protocol